BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15986446)

  • 21. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
    Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
    J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
    Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
    Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.
    Asai A; Karnan S; Ota A; Takahashi M; Damdindorj L; Konishi Y; Hossain E; Konishi H; Nagata A; Yokoo K; Hosokawa Y
    Gene; 2015 Mar; 558(2):220-6. PubMed ID: 25562418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene.
    Stark M; Assum G; Krone W
    Hum Genet; 1995 Nov; 96(5):619-23. PubMed ID: 8530015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
    Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
    Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas.
    Luijten M; Redeker S; van Noesel MM; Troost D; Westerveld A; Hulsebos TJ
    Eur J Hum Genet; 2000 Dec; 8(12):939-45. PubMed ID: 11175282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.
    Kehrer-Sawatzki H; Schmid E; Fünsterer C; Kluwe L; Mautner VF
    Am J Med Genet A; 2008 Mar; 146A(6):691-9. PubMed ID: 18265407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a cytogenetic 17q11.2 deletion in an NF1 patient with a contiguous gene syndrome.
    Riva P; Castorina P; Manoukian S; Dalprà L; Doneda L; Marini G; den Dunnen J; Larizza L
    Hum Genet; 1996 Dec; 98(6):646-50. PubMed ID: 8931693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2.
    Streubel B; Latta E; Kehrer-Sawatzki H; Hoffmann GF; Fonatsch C; Rehder H
    Am J Med Genet; 1999 Nov; 87(1):12-6. PubMed ID: 10528240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
    Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
    BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
    Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
    Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
    Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
    Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two independent chromosomal rearrangements, a very small (550 kb) duplication of the 7q subtelomeric region and an atypical 17q11.2 (NF1) microdeletion, in a girl with neurofibromatosis.
    Bartsch O; Vlcková Z; Erdogan F; Ullmann R; Novotná D; Spiegel M; Beyer V; Haaf T; Zechner U; Seemanová E
    Cytogenet Genome Res; 2007; 119(1-2):158-64. PubMed ID: 18160797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A search for evidence of somatic mutations in the NF1 gene.
    John AM; Ruggieri M; Ferner R; Upadhyaya M
    J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
    Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.
    Upadhyaya M; Roberts SH; Maynard J; Sorour E; Thompson PW; Vaughan M; Wilkie AO; Hughes HE
    J Med Genet; 1996 Feb; 33(2):148-52. PubMed ID: 8929953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.